These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38573497)

  • 1. Correction to: Clinical Characteristics of Pediatric Patients with LRBA Deficiency in Mexico.
    Liquidano-Perez E; Scheffler-Mendoza S; Bustamante-Ogando JC; ; Lopez-Herrera G
    J Clin Immunol; 2024 Apr; 44(3):83. PubMed ID: 38573497
    [No Abstract]   [Full Text] [Related]  

  • 2. To the Editor: Clinical Characteristics of Pediatric Patients with LRBA Deficiency in Mexico.
    Liquidano-Perez E; Scheffler-Mendoza S; Bustamante-Ogando JC; ; Lopez-Herrera G
    J Clin Immunol; 2024 Mar; 44(3):75. PubMed ID: 38443565
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
    Krone KA; Winant AJ; Vargas SO; Platt CD; Bartnikas LM; Janssen E; Lillehei C; Lee EY; Fishman MP; Casey A
    Pediatr Pulmonol; 2021 Jul; 56(7):2232-2241. PubMed ID: 33710794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunological and genetic characteristic of patients with clinical phenotype associated to LRBA-deficiency in Colombia.
    Martínez-Jaramillo C; Gutierrez-Hincapie S; Arango JCO; Vásquez-Duque GM; Erazo-Garnica RM; Franco JL; Trujillo-Vargas CM
    Colomb Med (Cali); 2019 Sep; 50(3):176-191. PubMed ID: 32284663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
    Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
    J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.
    Shamriz O; Shadur B; NaserEddin A; Zaidman I; Simanovsky N; Elpeleg O; Kerem E; Reiter J; Stepensky P
    Eur J Pediatr; 2018 Aug; 177(8):1163-1172. PubMed ID: 29777306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.
    Habibi S; Zaki-Dizaji M; Rafiemanesh H; Lo B; Jamee M; Gámez-Díaz L; Salami F; Kamali AN; Mohammadi H; Abolhassani H; Yazdani R; Aghamohammadi A; Anaya JM; Azizi G
    J Allergy Clin Immunol Pract; 2019; 7(7):2379-2386.e5. PubMed ID: 30995531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyautoimmunity in Patients with LPS-Responsive Beige-Like Anchor (LRBA) Deficiency.
    Azizi G; Abolhassani H; Zaki-Dizaji M; Habibi S; Mohammadi H; Shaghaghi M; Yazdani R; Anaya JM; Rezaei N; Hammarström L; Aghamohammadi A
    Immunol Invest; 2018 Jul; 47(5):457-467. PubMed ID: 29528757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency.
    Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S
    Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.
    Gámez-Díaz L; August D; Stepensky P; Revel-Vilk S; Seidel MG; Noriko M; Morio T; Worth AJJ; Blessing J; Van de Veerdonk F; Feuchtinger T; Kanariou M; Schmitt-Graeff A; Jung S; Seneviratne S; Burns S; Belohradsky BH; Rezaei N; Bakhtiar S; Speckmann C; Jordan M; Grimbacher B
    J Allergy Clin Immunol; 2016 Jan; 137(1):223-230. PubMed ID: 26768763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Flow Cytometry-Based Test for the Diagnosis of Lipopolysaccharide Responsive Beige-Like Anchor (LRBA) Deficiency.
    Gámez-Díaz L; Sigmund EC; Reiser V; Vach W; Jung S; Grimbacher B
    Front Immunol; 2018; 9():720. PubMed ID: 29740429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity.
    Azizi G; Bagheri Y; Yazdani R; Zaki-Dizaji M; Jamee M; Jadidi-Niaragh F; Kamali AN; Abolhassani H; Aghamohammadi A
    Allergol Immunopathol (Madr); 2019; 47(2):172-178. PubMed ID: 30193889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system manifestations of LRBA deficiency: case report of two siblings and literature review.
    Mangodt TC; Vanden Driessche K; Norga KK; Moes N; De Bruyne M; Haerynck F; Bordon V; Jansen AC; Jonckheere AI
    BMC Pediatr; 2023 Jul; 23(1):353. PubMed ID: 37443020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Stimulation with PMA/Ionomycin on CD4+ T Cell Proliferation and Surface CD4 Molecule Modulation of Patients with LRBA Deficiency and CVID with the Unsolved Genetic Defect.
    Salami F; Shariati S; Rasouli SE; Delavari S; Tavakol M; Sadri H; Asghari B; Yazdani R; Rezaei N; Abolhassani H; Azizi G
    Endocr Metab Immune Disord Drug Targets; 2022; 22(5):539-544. PubMed ID: 34886783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various phenotypes of
    Yao J; Gu H; Mou W; Chen Z; Ma J; Ma H; Li N; Zhang R; Wang T; Jiang J; Wu R
    Int J Immunopathol Pharmacol; 2022; 36():3946320221125591. PubMed ID: 36074705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.
    Alroqi FJ; Charbonnier LM; Baris S; Kiykim A; Chou J; Platt CD; Algassim A; Keles S; Al Saud BK; Alkuraya FS; Jordan M; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2018 Mar; 141(3):1050-1059.e10. PubMed ID: 28601686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis.
    Lévy E; Stolzenberg MC; Bruneau J; Breton S; Neven B; Sauvion S; Zarhrate M; Nitschké P; Fischer A; Magérus-Chatinet A; Quartier P; Rieux-Laucat F
    Clin Immunol; 2016 Jul; 168():88-93. PubMed ID: 27057999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
    Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
    Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population.
    Freund T; Baxter SK; Walsh T; Golan H; Kapelushnik J; Abramsohn-Goldenberg M; Benor S; Sarid N; Ram R; Alcalay Y; Segel R; Renbaum P; Stepensky P; King MC; Torgerson TR; Hagin D
    J Clin Immunol; 2023 Jan; 43(1):151-164. PubMed ID: 36063261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy.
    Soler-Palacín P; Garcia-Prat M; Martín-Nalda A; Franco-Jarava C; Rivière JG; Plaja A; Bezdan D; Bosio M; Martínez-Gallo M; Ossowski S; Colobran R
    Front Immunol; 2018; 9():2397. PubMed ID: 30386343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.